Healthequity (HQY) Receivables (2014 - 2026)

Healthequity's Receivables history runs 13 years deep, the most recent figure standing at $122.0 million for Q2 2026.

• On a quarterly basis, Receivables rose 4.94% year-over-year to $122.0 million in Q2 2026; TTM through Apr 2026 was $122.0 million, a 4.94% increase from a year earlier, with the FY2026 full-year figure at $123.7 million, up 4.82% from the prior year.
• Receivables declined to $122.0 million in Q2 2026 per HQY's latest filing, from $123.7 million in the prior quarter.
• Across five years, Receivables topped out at $123.7 million in Q1 2026 and bottomed at $86.0 million in Q2 2022.
• The 5-year median for Receivables is $105.6 million (2024), against an average of $103.6 million.
• Across the five-year window, Receivables rose 21.83% in 2022 and gained 2.38% in 2023, its largest moves.
• Year by year, Receivables stood at $87.7 million in 2022, then rose by 9.65% to $96.2 million in 2023, then gained by 10.95% to $106.7 million in 2024, then rose by 4.25% to $111.2 million in 2025, then increased by 9.67% to $122.0 million in 2026.
• Per Business Quant, the three latest HQY Receivables figures stand at $122.0 million (Q2 2026), $123.7 million (Q1 2026), and $111.2 million (Q4 2025).